Brief: Maxcyte Proposes Cancellation Of AIM Listing, Continues Nasdaq Listing
15/04/2025 07:41
April 15 (Reuters) - MaxCyte Inc MXCT.O: MAXCYTE INC - PROPOSES CANCELLATION OF AIM LISTING, CONTINUES NASDAQ LISTING Source text: ID:nRSO9923Ea Further company coverage: MXCT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on MaxCyte
See all newsMaxCyte Q1 revenue falls
Brief: Maxcyte Appoints Parmeet Ahuja As Chief Financial Officer
Brief: Maxcyte Announces Preliminary Unaudited Fourth Quarter And Full Year 2025 Financial Results
MaxCyte Q3 revenue falls 16% hurt by lower sales in instruments
Brief: MaxCyte Announces Planned CFO Transition In 2026